Apricus Biosciences Updates Strategic Corporate Objectives
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Apricus Biosciences (APRI) Gains Early on Refocused Strategy
April 6, 2016 7:13 AM EDTApricus Biosciences (Nasdaq: APRI) shares are notably higher in early trading Wednesday after the company announced an update to its strategic objectives. The company said it plans to "prioritize Vitaros commercial and regulatory activities and to deprioritize all other pipeline programs."
Shares of Apricus are indicated over 17 percent higher.
... More